• Home>
  • Stocks>
  • Balaxi Pharmaceuticals Ltd Share Price
Balaxi Pharmaceuticals Ltd share price logo

Balaxi Pharmaceuticals Ltd Share Price

NSE: BALAXI

BSE: 532597

Small Cap

Healthcare Sector

₹41.70

-1.09

(-2.55%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Balaxi Pharmaceuticals Ltd Stock Performance

as on November 6, 2025 at 10:37 am IST

  • Day's Low

    Day's High

    ₹41.5
    ₹42.9
    downward going graph

    0.48%

    Downside

    2.88%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹40.76
    ₹92
    downward going graph

    2.25%

    Downside

    120.62%

    Upside

    downward going graph

Balaxi Pharmaceuticals Ltd share price movements today

Previous Close
₹42.79
Open
₹41.70
Volume
8,966.00
Upper Circuit
₹51.34
Lower Circuit
₹34.23
Day's Low - High
₹41.5 - ₹42.9
52 Week Low - High
₹40.76 - ₹92

Balaxi Pharmaceuticals Ltd Historical Returns

1 Month Return
-0.86 %
3 Month Return
-10.2 %
1 Year Return
-50.77 %
3 Year Return
-65.82 %
5 Year Return
-72.24 %

Balaxi Pharmaceuticals Ltd Fundamentals

as on November 6, 2025 at 10:37 am IST

Market Cap

₹236.23 Cr

Return on Equity (ROE)

2.89

PE Ratio (TTM)

12.51

Return on capital employed (ROCE)

5.06

Industry PE ratio

42.27

Beta (LTM)

0.93

P/B Ratio

2.76

Dividend Yield

0

PEG Ratio

-2.36

Quarterly Earnings Growth YOY

-95.52

EPS (TTM)

4.54

Sector

Pharmaceuticals

Book Value

41.98

Technical Analysis

Bearish

View Technical Analysis

Balaxi Pharmaceuticals Ltd Stock Valuation

as on November 6, 2025 at 10:37 am IST

Balaxi Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-263.96x)

May 28, 2024

Today (12.51x)

November 4, 2025

Industry (42.27x)

November 4, 2025

Highest (66.45x)

September 21, 2020

LowHigh

Today’s Price to Earnings Ratio: 12.51x

Balaxi Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Balaxi Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Balaxi Pharmaceuticals Ltd image
Balaxi Pharmaceuticals Ltd
NA236.23-14.45%0.5925292
OneSource Specialty Pharma Ltd image
OneSource Specialty Pharma Ltd
BUY20,998.201.44%0.57-181,444
Zenlabs Ethica Ltd image
Zenlabs Ethica Ltd
NA20.837.34%0.00NA51
Emcure Pharmaceuticals Ltd image
Emcure Pharmaceuticals Ltd
BUY25,111.66-0.51%0.637077,896
Biofil Chemicals & Pharmaceuticals Ltd image
Biofil Chemicals & Pharmaceuticals Ltd
NA64.48-13.19%0.00133
See all

Balaxi Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Balaxi Pharmaceuticals Ltd Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:25% versus previous 30 day period

Balaxi Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
86.58
80.68
65.96
54.72
60.79
59.83
65.62
77.38
73.29
76.27
70.74
Other Income
-4.57
-0.22
-1.01
5.93
1.51
-0.7
-1.85
-4.11
3.94
-1.69
-1.78
Total Income
82.02
80.46
64.95
60.65
62.29
59.14
63.77
73.27
77.23
74.57
68.97
Expenses
71.29
67.94
103.78
43.96
47.13
46.37
55.54
66.79
69.3
63.71
66.59
Operating Profit
15.29
12.74
-37.82
10.76
13.66
13.46
10.08
10.59
3.99
12.56
4.15
Operating Profit Margin %
17.66%
15.79%
-57.34%
19.66%
22.47%
22.5%
15.36%
13.69%
5.44%
16.47%
5.87%
Profit Before Interest, Tax and Depreciation
10.73
12.52
-38.84
16.69
15.17
12.77
8.24
6.48
7.93
10.86
2.37
Interest
0.01
0.27
0.29
0.37
0.41
0.61
0.37
0.45
1.38
0.74
1.01
Depreciation
0.19
1.19
0.29
0.66
0.48
0.67
0.49
0.46
0.48
0.46
0.46
Profit Before Tax
10.53
11.06
-39.42
15.66
14.28
11.49
7.38
5.57
6.07
9.66
0.9
Tax Paid
2.3
2.97
1.93
1.24
0.68
0.56
0.89
0.97
0.71
1.02
0.61
Profit After Tax
8.23
8.1
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
Total Net profit including share of profit / Loss from associate company
8.23
8.1
-41.34
14.43
13.59
10.93
6.48
4.59
5.36
8.64
0.29
EPS
8.21
8.01
-40.49
14.1
13.29
10.41
1.17
0.84
0.97
1.56
0.05
Actual EPS
8.21
8.01
-40.49
14.1
13.29
10.41
1.17
0.84
0.97
1.56
0.05
Adjusted EPS
1.64
1.6
-8.1
2.82
2.66
2.08
1.17
0.84
0.97
1.56
0.05
Diluted EPS
8.03
7.86
-39.93
14.06
13.22
10.38
1.17
0.84
0.97
1.56
0.05

Balaxi Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
13.6
45.63
231.33
279.39
336.43
241.29
292.56
Other Income
0.81
0.59
2.23
4.97
2.64
-2.65
-3.72
Total Income
14.4
46.23
233.56
284.36
339.07
238.65
288.84
Expenses
11.96
37.44
188.92
229.18
279.89
194.56
255.35
Operating Profit
1.64
8.19
42.41
50.21
56.54
46.73
37.21
Operating Profit Margin %
12.06%
17.95%
18.33%
17.97%
16.81%
19.37%
12.72%
Profit Before Interest, Tax and Depreciation
2.44
8.79
44.64
55.18
59.17
44.08
33.5
Interest
-
-
0.01
0.14
0.5
1.68
2.93
Depreciation
-
0.01
0.3
0.51
1.75
2.1
1.89
Profit Before Tax
2.44
8.78
44.33
54.53
56.92
40.3
28.68
Tax Paid
0.47
2.68
6.19
6.86
10.96
4.4
3.6
Profit After Tax
1.97
6.1
38.14
47.66
45.96
35.91
25.07
Total Net profit including share of profit / Loss from associate company
1.97
6.1
38.14
47.66
45.96
35.91
25.07
EPS
6.47
8.12
38.14
47.66
45.81
-2.32
4.54
Actual EPS
6.47
8.12
38.14
47.66
45.81
-2.32
4.54
Adjusted EPS
1.29
1.62
7.63
9.53
9.16
-0.46
4.54
Diluted EPS
6.47
8.12
38.14
47.66
45.4
-2.32
4.54

Balaxi Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-1.51
-14.04
-
34.14
6.08
4.87
-35
Cash Flow from Investing Activities
-0.01
-0.18
-5.98
-27.87
-8.31
-1.57
-2
Cash Flow from Financing Activities
-
18.1
3.65
-0.16
25.51
30.25
33.87
Net Cash Flow
-1.51
3.88
-2.32
5.53
21.02
34.07
-22.89

Balaxi Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
72.69%
71.57%
71.22%
71.22%
71.22%
66.36%
66.36%
65.99%
65.99%
65.99%
65.99%
65.99%
65.99%
DII
0.03%
0.03%
0.03%
0.03%
0.03%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
8.33%
9.75%
10.18%
10.18%
10.18%
16.54%
16.54%
17.11%
17.5%
17.5%
17.96%
25.12%
30.49%
Total Outstanding Shares
1,00,24,500
1,01,81,250
1,02,30,200
1,02,30,200
1,02,30,200
1,09,80,500
1,09,80,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
5,52,07,500
Total Shareholders
4,730
4,859
5,123
5,047
5,045
5,132
5,132
6,586
7,863
8,529
9,994
13,737
14,620

Balaxi Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Balaxi Pharmaceuticals Ltd.

  • Balaxi Pharmaceuticals Ltd Earnings Results

    Balaxi Pharmaceuticals Ltd’s net profit fell -95.52% since last year same period to ₹0.29Cr in the Q1 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -96.64% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Balaxi Pharmaceuticals Ltd Dividends May,2022

    In the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 per share on 23 May 2022 - translating a dividend yield of 1.17%.

    Read More about Dividends

Insights on Balaxi Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.12% to 30.49% in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.99% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 77.23 Cr → 68.97 Cr (in ₹), with an average decrease of 5.5% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.87% to 3.50% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, BALAXI stock has moved down by -52.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 8.64 Cr → 0.29 Cr (in ₹), with an average decrease of 96.6% per quarter

About Balaxi Pharmaceuticals Ltd

Balaxi Ventures Limited formerly known as The Anandam Rubber Company, is a public limited company established in India since 1942. In 1989, the company sold its plantations to focus on investments and trading. The Securities and Exchange Board of India (SEBI) issued a revised Exit Policy in 2012 for derecognized/non-operational stock exchanges. Consequently, Madras Stock Exchange was derecognized by SEBI and The Anandam Rubber Company applied to list its shares with the National Stock Exchange of India (NSE) in January 2015.
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.

Revenue: ₹70.74Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.29Cr as on June 2025 (Q1 FY26)
Listing date: 30 Nov, 2015
Chairperson Name: Ashish Maheshwari
OrganisationBalaxi Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish Maheshwari
E-voting on sharesClick here to vote

FAQs

What is Balaxi Pharmaceuticals Ltd share price today?

Balaxi Pharmaceuticals Ltd share price today stands at ₹41.7 as on . Balaxi Pharmaceuticals Ltd share today touched a day high of ₹42.9 and a low of ₹41.5.

What is the 52 week high and 52 week low range for Balaxi Pharmaceuticals Ltd share?

Balaxi Pharmaceuticals Ltd touched a 52 week high of ₹92 and a 52 week low of ₹40.76. Balaxi Pharmaceuticals Ltd share price today i.e. is trending at ₹41.7, which is -54.67% down from its 52 week high and 2.31% up from its 52 week low.

What is Balaxi Pharmaceuticals Ltd's market capitalisation today?

Balaxi Pharmaceuticals Ltd market capitalisation is ₹236.23 Cr as on .

How to buy Balaxi Pharmaceuticals Ltd shares?

To buy Balaxi Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BALAXI or Balaxi Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Balaxi Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Balaxi Pharmaceuticals Ltd trading volume today?

Balaxi Pharmaceuticals Ltd trading volume is 8,966.00 as on . This means that 8,966.00 shares of Balaxi Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.